These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2004-000438-35||A study of the Efficacy and Safety of Teduglutide in subjects with Parenteral Nutritional Dependant Short Bowel Syndrome||2007-07-06||due-trials|
|Not reported||2004-000439-27||A Study of the Safety and Efficacy of Teduglutide in Subjects with Parenteral Nutrition-Dependant Short Bowel Syndrome Who Completed Protocol CL0600-004||2008-01-24||due-trials|
|Not reported||2008-005063-34||A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP558, a Recombinant Human Parathyroid Hormone [rhPTH(1-84)] for the Treatment of Adults with Hypoparathyroidi...||2011-09-21||due-trials|
|Listed as ongoing, but also has a completion date||2008-006193-15||A 24-Week Study of the Efficacy and Safety of Teduglutide in Subjects with Parenteral Nutrition-Dependent Short Bowel Syndrome||2011-02-25||bad-data|
|Listed as ongoing, but also has a completion date||2009-011679-65||A Long Term, Open Labeled Study with Teduglutide for Subjects with Parenteral Nutrition-Dependent Short Bowel Syndrome who completed Study Cl0600020||2013-02-11||bad-data|
|Not reported||2011-001265-40||A 6-Month Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults with Hypoparathyroidism - A Clinica...||2012-09-10||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2013-004588-30||A 12-Week Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects Aged 1 Year through 17 Years, with Short Bowel Syndrome who are Dependent on Parenteral Support||2015-03-13||bad-data|
|Reported results||2015-002252-27||A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age with Short Bowel Syndrome who are Dependent on ...||2017-08-18||due-trials|
|Ongoing||2015-003108-22||An Open-label, Single-dose Study to Determine the Pharmacokinetic/Pharmacodynamic Profile of Parathyroid Hormone (rDNA) Administered Subcutaneously at a Dose of||not-yet-due|